Cytokines, Chemokines, and Chemokine Receptors Quantitative Expressions in Patients with Ovarian Cancer

Overview

Journal Iran J Med Sci

Publisher Shiraz University of Medical Sciences

Specialty General Medicine

Date 2015 May 23

PMID 25999622

Citations 2

Authors

Somayeh Rezaeifard

Mahboobeh Razmkhah

Minoo Robati

Mozhdeh Momtahan

Abbas Ghaderi

Affiliations

Soon will be listed here.

Abstract

Background: Cytokines, chemokines, and chemokine receptors regulate the proliferation and survival of tumor cells, angiogenesis, and metastasis to other organs. This network of ligands and receptors has been used in molecular targeting of cancer.

Methods: We compared the mRNA expression of CXCR3, CXCL-10, CXCR4, CXCL-12, IL-4, and IL-10 in tissues of benign and malignant ovarian tumors by qRT-PCR method and evaluated serum IL-10 and CA-125 content of these patients by ELISA during one year.

Results: Our result showed a trend toward a higher expression of CXCR4 in malignant ovarian tissues compared with the benign ovarian cysts (P>0.05). However, SDF-1, IP-10, IL-4, CXCR3, and IL-10 had a lower trend in mRNA expression in malignant ovarian tissues compared to the benign cyst tissues. Except for IL-4 (P=0.01) and SDF-1 (P=0.02), the data for other factors were not statistically significant. A trend toward higher concentration of IL-10 was observed in the serum of ovarian cancer patients compared to those with benign cysts; however, the difference was not significant. CA-125 concentration in the serum of ovarian cancer patients was higher than that of benign cyst patients (P=0.05).

Conclusion: According to results obtained, we hypothesize that the lower expression of SDF-1 in malignant tissues may have an important role in ovarian tumor growth. However, this hypothesis requires more investigation. Higher levels of CA125 and IL-10 in the serum of patients might indicate that the combination of these biomarkers could be used for distinguishing patients with ovarian cancer from those with benign cysts.

Citing Articles

Stromal IL2 is related to the neutrophil/lymphocyte ratio in epithelial ovarian cancer.

Santos T, Jammal M, Silveira T, Murta E, Nomelini R Pathologica. 2019; 111(2):62-66.

PMID: 31388197 PMC: 8186009. DOI: 10.32074/1591-951X-62-18.

Development of Peritoneal Carcinomatosis in Epithelial Ovarian Cancer: A Review.

van Baal J, van Noorden C, Nieuwland R, Van de Vijver K, Sturk A, van Driel W J Histochem Cytochem. 2017; 66(2):67-83.

PMID: 29164988 PMC: 5794203. DOI: 10.1369/0022155417742897.

References

Hassan S, Baccarelli A, Salvucci O, Basik M . Plasma stromal cell-derived factor-1: host derived marker predictive of distant metastasis in breast cancer. Clin Cancer Res. 2008; 14(2):446-54. DOI: 10.1158/1078-0432.CCR-07-1189. View

Lech-Maranda E, Bienvenu J, Michallet A, Houot R, Robak T, Coiffier B . Elevated IL-10 plasma levels correlate with poor prognosis in diffuse large B-cell lymphoma. Eur Cytokine Netw. 2006; 17(1):60-6. View

Belmadani A, Tran P, Ren D, Assimacopoulos S, Grove E, Miller R . The chemokine stromal cell-derived factor-1 regulates the migration of sensory neuron progenitors. J Neurosci. 2005; 25(16):3995-4003. PMC: 4461238. DOI: 10.1523/JNEUROSCI.4631-04.2005. View

Kushitani K, Takeshima Y, Amatya V, Furonaka O, Sakatani A, Inai K . Immunohistochemical marker panels for distinguishing between epithelioid mesothelioma and lung adenocarcinoma. Pathol Int. 2007; 57(4):190-9. DOI: 10.1111/j.1440-1827.2007.02080.x. View

Kiefer F, Siekmann A . The role of chemokines and their receptors in angiogenesis. Cell Mol Life Sci. 2011; 68(17):2811-30. PMC: 11115067. DOI: 10.1007/s00018-011-0677-7. View

Fushimi T, OConnor T, Crystal R . Adenoviral gene transfer of stromal cell-derived factor-1 to murine tumors induces the accumulation of dendritic cells and suppresses tumor growth. Cancer Res. 2006; 66(7):3513-22. DOI: 10.1158/0008-5472.CAN-05-1493. View

Darash-Yahana M, Pikarsky E, Abramovitch R, Zeira E, Pal B, Karplus R . Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis. FASEB J. 2004; 18(11):1240-2. DOI: 10.1096/fj.03-0935fje. View

Morini M, Astigiano S, Gitton Y, Emionite L, Mirisola V, Levi G . Mutually exclusive expression of DLX2 and DLX5/6 is associated with the metastatic potential of the human breast cancer cell line MDA-MB-231. BMC Cancer. 2010; 10:649. PMC: 3003273. DOI: 10.1186/1471-2407-10-649. View

Zagzag D, Krishnamachary B, Yee H, Okuyama H, Chiriboga L, Ali M . Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor. Cancer Res. 2005; 65(14):6178-88. DOI: 10.1158/0008-5472.CAN-04-4406. View

10.

Liang J, Zhu S, Bruggeman R, Zaino R, Evans D, Fleming J . High levels of expression of human stromal cell-derived factor-1 are associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma. Cancer Epidemiol Biomarkers Prev. 2010; 19(10):2598-604. DOI: 10.1158/1055-9965.EPI-10-0405. View

11.

Otsuka S, Bebb G . The CXCR4/SDF-1 chemokine receptor axis: a new target therapeutic for non-small cell lung cancer. J Thorac Oncol. 2008; 3(12):1379-83. DOI: 10.1097/JTO.0b013e31818dda9d. View

12.

Kulbe H, Chakravarty P, Leinster D, Charles K, Kwong J, Thompson R . A dynamic inflammatory cytokine network in the human ovarian cancer microenvironment. Cancer Res. 2011; 72(1):66-75. PMC: 3252703. DOI: 10.1158/0008-5472.CAN-11-2178. View

13.

Zou W, Machelon V, Borvak J, Nome F, Isaeva T, Wei S . Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat Med. 2001; 7(12):1339-46. DOI: 10.1038/nm1201-1339. View

14.

Akishima-Fukasawa Y, Nakanishi Y, Ino Y, Moriya Y, Kanai Y, Hirohashi S . Prognostic significance of CXCL12 expression in patients with colorectal carcinoma. Am J Clin Pathol. 2009; 132(2):202-10. DOI: 10.1309/AJCPK35VZJEWCUTL. View

15.

Lee B, Lee T, Avraham S, Avraham H . Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells. Mol Cancer Res. 2004; 2(6):327-38. View

16.

Zeni E, Mazzetti L, Miotto D, Lo Cascio N, Maestrelli P, Querzoli P . Macrophage expression of interleukin-10 is a prognostic factor in nonsmall cell lung cancer. Eur Respir J. 2007; 30(4):627-32. DOI: 10.1183/09031936.00129306. View

17.

Hart K, Byrne K, Molloy M, Usherwood E, Berwin B . IL-10 immunomodulation of myeloid cells regulates a murine model of ovarian cancer. Front Immunol. 2012; 2:29. PMC: 3342001. DOI: 10.3389/fimmu.2011.00029. View

18.

Kryczek I, Zou L, Rodriguez P, Zhu G, Wei S, Mottram P . B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. J Exp Med. 2006; 203(4):871-81. PMC: 2118300. DOI: 10.1084/jem.20050930. View

19.

Machelon V, Gaudin F, Camilleri-Broet S, Nasreddine S, Bouchet-Delbos L, Pujade-Lauraine E . CXCL12 expression by healthy and malignant ovarian epithelial cells. BMC Cancer. 2011; 11:97. PMC: 3070683. DOI: 10.1186/1471-2407-11-97. View

20.

Scotton C, Wilson J, Scott K, Stamp G, Wilbanks G, Fricker S . Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. Cancer Res. 2002; 62(20):5930-8. View